ArticleBMC pulmonary medicine2025
Trends of asthma mortality in china: a comprehensive analysis by population, region, and sex with future projections.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAsthma prevalence in China has risen due to rapid industrialization, environmental changes, and improved diagnostics. While efforts in asthma control have expanded nationwide, research on asthma-related mortality remains limited. Understanding death patterns from asthma is important to identify key regions and populations at risk, and to support more effective prevention and treatment strategies suitable for China's population and healthcare system.
methodsWe conducted a retrospective study using China CDC's DSPs data, stratifying asthma mortality by sex, region, urban-rural residence, and age. This is a nationwide population and mortality survey study, including data on the total surveyed population and deaths from 2008 to 2021, covering approximately 25% of the total population. Trend analysis was conducted on the total surveyed population stratified by age, sex, and region to explore patterns of mortality changes. Based on mortality trend changes, decomposition analysis of asthma mortality and future trend projections considering population changes were performed to further identify key regions and populations.
resultsAsthma mortality in China showed significant regional variation, with higher rates in the southwestern region and lower rates in northern and coastal regions. The crude mortality rate of asthma in China (2008-2021) generally decreased, especially in the older population (33.8% decline), but increased in individuals aged 15-19 in recent years. Mortality rates peaked around 2015 and then declined annually. Geographically, the most substantial decline rate was observed in the eastern region (10.5% decline), followed by the central region (8.1% decline). However, the decline rate in the western region was less pronounced and even displayed an upward trend, particularly in urban areas. Both decomposition analysis and BAPC analysis revealed an unclear mortality trend in urban areas of the western region, while mortality declined in the eastern and central regions.
conclusionThe asthma mortality rate in China has experienced a comprehensive decline over the past decade. However, rates in certain groups, like the older population and those in western China, remained higher than the global average, while in the youth population a slight upward trend was observed. Addressing these disparities is crucial for future efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.